Home  >  Products  >  C16orf57 (chromosome 16 open reading frame 57 ) Blocking Peptide (the C terminal of C16orf57)(100ug)
C16orf57 (chromosome 16 open reading frame 57 ) Blocking Peptide (the C terminal of C16orf57)(100ug)

C16orf57 (chromosome 16 open reading frame 57 ) Blocking Peptide (the C terminal of C16orf57)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-C16orf57 Antibody (ARP62380_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62380
Size: 100ug
Weight: 29kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a protein with several conserved domains, however, its exact function is not known. Mutations in this gene are associated with poikiloderma with neutropenia (PN), which shows phenotypic overlap with Rothmund-Thomson syndrome (RTS) caused by mutations in the RECQL4 gene. It is believed that this gene product interacts with RECQL4 protein via SMAD4 proteins, explaining the partial clinical overlap between PN and RTS. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.
Alternative names: FLJ13154; HVSL1; PN